Revolution Medicines, Inc.

RVMD·NASDAQ·$154.89Share Price as of 11/2·$33BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202502/25/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report10/13/26 8-KCurrent report09/01/26 8-KCurrent report08/26/26 8-KCurrent report08/05/26 8-KCurrent report06/22/26

Prospectuses and Registrations

424B5Prospectus supplement04/15/26 424B5Prospectus supplement04/15/26 FWPFree writing prospectus04/15/26 424B5Prospectus supplement04/13/26 424B5Prospectus supplement04/13/26

Proxies

DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/27/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/25/24

Ownership

Form 4Insider transaction10/28/26 Form 4Insider transaction10/01/26 144Proposed sale of securities09/29/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/28/26

Other

ARSAnnual report to shareholders04/28/26 305B2305B204/15/26 ARSAnnual report to shareholders04/29/25 UPLOADLetter from the SEC04/26/24 ARSAnnual report to shareholders04/25/24